The present invention relates to the treatment and/or prevention of aortic valve stenosis (AVS) and valve mineralization. Particularly, the invention provides a target for intervention in the treatment or prevention of AVS through the administration of the P2Y2 receptor agonists. Also, the invention provides means to treat hypertension related to decreased arterial compliance and vascular calcification.
